demonstrated that PIM2 mediated phosphorylation of HSF1 at Thr120 to regulate HSF1 protein stability, and induce PD-L1 expression in breast cancer, which suggested that it might affect immune therapy response (50). This evidence concerns the gene HSF1 and breast carcinoma.